ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,127.44
0.54%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ID Biomedical - Common Shares (MM) (IDBE)

  7. ID Biomedical - Common Shares (MM) (IDBE) News

ID Biomedical (IDBE)

ID Biomedical - Common Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IDBE
DateTimeSourceHeadlineSymbolCompany
08/12/200515:00PR Newswire (US)ID Biomedical announces closing of acquisition by GlaxoSmithKlineNASDAQ:IDBE
07/12/200501:40PR Newswire (US)ID Biomedical announces receipt of court approval for acquisition by GlaxoSmithKlineNASDAQ:IDBE
05/12/200514:15PR Newswire (US)ID Biomedical provides update on application for court approval of acquisition by GlaxoSmithKlineNASDAQ:IDBE
18/11/200522:06PR Newswire (US)ID Biomedical announces rescheduling of court hearing to approve acquisition by GlaxoSmithKlineNASDAQ:IDBE
16/11/200522:28PR Newswire (US)ID Biomedical announces results of securityholders' votes relating to acquisition by GlaxoSmithKlineNASDAQ:IDBE
10/11/200515:28PR Newswire (US)ID Biomedical reports 2005 third quarter resultsNASDAQ:IDBE
24/10/200515:40PR Newswire (US)ID Biomedical Provides Update on Vaccine Development ProgramsNASDAQ:IDBE
21/10/200500:54PR Newswire (US)ID Biomedical announces mailing of meeting materialsNASDAQ:IDBE
07/09/200517:06PR Newswire (US)GlaxoSmithKline To Acquire ID Biomedical CorporationNASDAQ:IDBE
07/09/200516:31PR Newswire (US)GlaxoSmithKline To Acquire ID Biomedical CorporationNASDAQ:IDBEID Biomedical - Common Shares (MM)
15/08/200522:00PR Newswire (US)ID Biomedical reports 2005 second quarter resultsNASDAQ:IDBE
10/08/200520:10PR Newswire (US)ID Biomedical announces 2005 second quarter release date and conference callNASDAQ:IDBE
12/07/200515:00PR Newswire (US)ID Biomedical's flu vaccine granted Fast Track status by FDANASDAQ:IDBE
26/05/200515:30PR Newswire (US)ID Biomedical announces webcast of 2005 Annual General Meeting of ShareholdersNASDAQ:IDBE
20/05/200516:57PR Newswire (US)ID Biomedical announces webcast of 2005 Annual General Meeting of ShareholdersNASDAQ:IDBE
16/05/200522:00PR Newswire (US)ID Biomedical reports 2005 first quarter resultsNASDAQ:IDBE
11/05/200515:30PR Newswire (US)ID Biomedical announces 2005 first quarter release date and conference callNASDAQ:IDBE
30/03/200516:42PR Newswire (US)ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral Clinical Trial in the U.S.NASDAQ:IDBE
22/03/200515:04PR Newswire (US)ID Biomedical receives positive data from clinical testing of its Group-Common Pneumococcal VaccineNASDAQ:IDBE
16/03/200521:01PR Newswire (US)ID Biomedical reports fiscal 2004 year end resultsNASDAQ:IDBE
15/03/200514:30PR Newswire (US)ID Biomedical to pursue U.S. accelerated approval process for its influenza vaccineNASDAQ:IDBE
14/03/200515:40PR Newswire (US)ID Biomedical announces 2004 year end earnings release date and conference callNASDAQ:IDBE
04/03/200514:30PR Newswire (US)ID Biomedical closes sale and leaseback transactionsNASDAQ:IDBE
26/01/200514:15PR Newswire (US)ID Biomedical Announces Immunogenicity Results from Phase II Trial of StreptavaxNASDAQ:IDBE
19/01/200514:15PR Newswire (US)ID Biomedical begins development of pandemic influenza vaccineNASDAQ:IDBE
13/01/200516:34PR Newswire (US)ID Biomedical announces final results from field efficacy trial of its intranasal flu vaccineNASDAQ:IDBE
10/01/200516:16PR Newswire (US)ID Biomedical announces the beginning of a U.S. phase I clinical trial for plague vaccine candidateNASDAQ:IDBE
10/01/200514:15PR Newswire (US)ID Biomedical Closes Financing TransactionNASDAQ:IDBE
10/01/200514:01PR Newswire (US)CSC's DVC Enters Clinical Trial for Plague Vaccine CandidateNASDAQ:IDBEID Biomedical - Common Shares (MM)
07/01/200514:15PR Newswire (US)ID Biomedical receives clearance for Fluviral clinical testing in the U.S.NASDAQ:IDBE
 Showing the most relevant articles for your search:NASDAQ:IDBE

Your Recent History

LSE
PET
Petrel Resources
LSE
GFM
Griffin Mining
LSE
GOLD
LSE
VAST
Vast Resources
LSE
ALBA
Alba Mineral Resources
LSE
ITV
Itv
LSE
SYME
Supply@me Capital
LSE
INSG
Insig Ai
LSE
BBSN
Brave Bison
LSE
LTI
Lindsell Train Investment
LSE
JSE
Jadestone Energy
LSE
POS
Plexus
LSE
HE1
Helium One Global
LSE
SCE
Surface Transforms
LSE
TERN
Tern
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved